- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Human Metabolome Technologies Inc (6090)
Human Metabolome Technologies Inc stock price live, this page displays TYO 6090 stock exchange data. View the 6090 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Human Metabolome Technologies Inc real time stock price chart below.
What Is the Human Metabolome Technologies Inc Stock Price Today?
The Human Metabolome Technologies Inc stock price today is 758.0.
What Is the Stock Symbol for Human Metabolome Technologies Inc?
The stock symbol for Human Metabolome Technologies Inc is "6090."
What Stock Exchange Does Human Metabolome Technologies Inc Trade On?
Human Metabolome Technologies Inc is listed and trades on the Tokyo stock exchange.
Is Human Metabolome Technologies Inc a Good Stock to Buy?
Determining whether Human Metabolome Technologies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6090 quote. (ISIN: JP3794530000)
What Is the Human Metabolome Technologies Inc Stock Price Today?
The Human Metabolome Technologies Inc stock price today is 758.0.
What Is the Stock Symbol for Human Metabolome Technologies Inc?
The stock symbol for Human Metabolome Technologies Inc is "6090."
What Stock Exchange Does Human Metabolome Technologies Inc Trade On?
Human Metabolome Technologies Inc is listed and trades on the Tokyo stock exchange.
Is Human Metabolome Technologies Inc a Good Stock to Buy?
Determining whether Human Metabolome Technologies Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6090 quote. (ISIN: JP3794530000)
Tokyo
Currency in JPY
758.0
+9.0(+1.20%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
752.0
758.0
52 wk Range
501.0
869.0
6090 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
6090 is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
752.0758.0
52 wk Range
501.0869.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.98%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.98%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
6090 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a strong free cash flow yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Human Metabolome Tech Company Profile
Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan. The company provides metabolome analysis services; and global profiling, targeted assays, flux analysis, and lipidomics services. It also develops biomarkers, such as Phosphorylethanolamine, a biomarker for major depressive disorder and measured in blood plasma. The company offers solutions for cancer metabolism, metabolic flux analysis, infectious diseases, basic science, preclinical and clinical, food and nutrition, and microbiome applications. It has a collaboration with the Institute for Advanced Biosciences and Keio University for the development of metabolome analysis technology. The company was incorporated in 2003 and is based in Tsuruoka, Japan.
Compare 6090 to Peers and Sector
Metrics to compare | 6090 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6090PeersSector | |
|---|---|---|---|---|
P/E Ratio | 13.8x | 12.3x | −0.5x | |
PEG Ratio | 1.15 | −0.08 | 0.00 | |
Price/Book | 2.1x | 1.9x | 2.6x | |
Price / LTM Sales | 2.9x | 3.6x | 3.1x | |
Upside (Analyst Target) | - | 11.7% | 46.1% | |
Fair Value Upside | Unlock | 20.6% | 6.9% | Unlock |
Earnings
Latest Release
May 14, 2025
EPS / Forecast
35.78 / --
Revenue / Forecast
582.00M / --
FAQ
What Is the Human Metabolome Tech (6090) Stock Price Today?
The Human Metabolome Tech stock price today is 758.00.
What Stock Exchange Does Human Metabolome Tech Trade On?
Human Metabolome Tech is listed and trades on the Tokyo Stock Exchange stock exchange.
What Is the Stock Symbol for Human Metabolome Tech?
The stock symbol for Human Metabolome Tech is "6090."
Does Human Metabolome Tech Pay Dividends? What’s The Current Dividend Yield?
The Human Metabolome Tech dividend yield is 1.98%.
What Is the Human Metabolome Tech Market Cap?
As of today, Human Metabolome Tech market cap is 4.40B.
What Is Human Metabolome Tech's Earnings Per Share (TTM)?
The Human Metabolome Tech EPS (TTM) is 53.98.
When Is the Next Human Metabolome Tech Earnings Date?
Human Metabolome Tech will release its next earnings report on 07 Aug 2025.
From a Technical Analysis Perspective, Is 6090 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Human Metabolome Tech Stock Split?
Human Metabolome Tech has split 0 times.
How Many Employees Does Human Metabolome Tech Have?
Human Metabolome Tech has 58 employees.
What is the current trading status of Human Metabolome Tech (6090)?
As of 12 Jul 2025, Human Metabolome Tech (6090) is trading at a price of 758.00, with a previous close of 749.00. The stock has fluctuated within a day range of 752.00 to 758.00, while its 52-week range spans from 501.00 to 869.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.